Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5917051 | 0.96 | SCP2 (0.60) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL13521801 | 0.90 | SCP2 (0.67) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL62370 | 0.86 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL5916783 | 0.84 | SCP2 (0.58) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL5916788 | 0.81 | MEN1 (0.50) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL19646592 | 0.79 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL14267417 | 0.79 | SCP2 (1.00) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL8858355 | 0.78 | NPC1 (0.76) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL16812947 | 0.78 | SCP2 (0.74) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL7812704 | 0.78 | SCP2 (0.93) | SCP2MEN1NPC1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060286626-A1 | Selective chromophores | WESTMAN GUNNAR | 2006-12-21 | — | — | US | claimed |
| EP-1509508-A1 | SELECTIVE CHROMOPHORES | Westman, Gunnar (SE) | 2005-03-02 | — | — | EP | claimed |
| WO-2003104210-A1 | SELECTIVE CHROMOPHORES | CHALMERS TECHNOLOGY LICENSING AB (SE) | 2003-12-18 | — | — | WO | claimed |
| US-20060286626-A1 | Selective chromophores | WESTMAN GUNNAR | 2006-12-21 | — | — | US | disclosed |
| EP-1509508-A1 | SELECTIVE CHROMOPHORES | Westman, Gunnar (SE) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003104210-A1 | SELECTIVE CHROMOPHORES | CHALMERS TECHNOLOGY LICENSING AB (SE) | 2003-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060286626-A1 | Selective chromophores | MKI67, TUBB6, BOD1L1 | SCP2 4286/4885MEN1 2146/4885NPC1 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.